Eisai Archives - Express Pharma

Eisai completes rolling submission to US FDA for LEQEMBI IQLIK supplemental biologics license application

Merck & Co., Inc. and Eisai announce Phase 3 trial results for WELIREG plus LENVIMA in advanced renal cell carcinoma

Eisai selected as Supplier Engagement Leader by CDP

EMA reiterates positive recommendation for Eisai-Biogen’s Alzheimer’s drug

Elucidation of part of the mechanism by which Lecanemab slows the progression of Alzheimer’s

Balancing cost and value with TCO

DIA’s India Annual Meeting to host discussions on evolving regulatory landscape

Shares of Japan’s Eisai tumble after EU rejects Alzheimer’s drug

Eisai selects Medidata’s Clinical Data Studio to enhance clinical trial efficiency

Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData